{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:41:57Z","timestamp":1790790117722,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","psychiatricnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Psychiatric Nursing"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.apnu.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:54:52Z","timestamp":1616784892000},"page":"284-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing"],"prefix":"10.1016","volume":"35","author":[{"given":"Jessie S.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O.","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Stovall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.apnu.2021.03.006_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JHD-2012-120002","article-title":"The patient education program for Huntington\u2019s disease (PEP-HD)","volume":"1","author":"A\u2019Campo","year":"2012","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"3","key":"10.1016\/j.apnu.2021.03.006_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JHD-180293","article-title":"Clinical management of neuropsychiatric symptoms of Huntington disease: Expert-based consensus guidelines on agitation, anxiety, apathy, psychosis and sleep disorders","volume":"7","author":"Anderson","year":"2018","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"10","key":"10.1016\/j.apnu.2021.03.006_bb0015","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ejhg.2016.36","article-title":"22 years of predictive testing for Huntington\u2019s disease: The experience of the UK Huntington\u2019s Prediction Consortium","volume":"24","author":"Baig","year":"2016","journal-title":"European Journal of Human Genetics"},{"issue":"9","key":"10.1016\/j.apnu.2021.03.006_bb0020","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00415-012-6415-8","article-title":"Substance abuse may be a risk factor for earlier onset of Huntington disease","volume":"259","author":"Byars","year":"2012","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1016\/j.apnu.2021.03.006_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.neuropsych.13070169","article-title":"Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington\u2019s disease (PBA-s) in the TRACK-HD and REGISTRY studies","volume":"27","author":"Callaghan","year":"2015","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"4s","key":"10.1016\/j.apnu.2021.03.006_bb0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.apmr.2018.08.175","article-title":"The TBI-CareQOL measurement system: Development and preliminary validation of health-related quality of life measures for caregivers of civilians and service members\/veterans with traumatic brain injury","volume":"100","author":"Carlozzi","year":"2019","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"10 Suppl","key":"10.1016\/j.apnu.2021.03.006_bb0035","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.apmr.2011.01.025","article-title":"The neurology quality-of-life measurement initiative","volume":"92","author":"Cella","year":"2011","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"4","key":"10.1016\/j.apnu.2021.03.006_bb0040","first-page":"219","article-title":"Behavioral changes in Huntington disease","volume":"14","author":"Craufurd","year":"2001","journal-title":"Neuropsychiatry, Neuropsychology, and Behavioral Neurology"},{"issue":"12","key":"10.1016\/j.apnu.2021.03.006_bb0045","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archpediatrics.2009.214","article-title":"Adverse childhood experiences and adult risk factors for age-related disease: Depression, inflammation, and clustering of metabolic risk markers","volume":"163","author":"Danese","year":"2009","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"1\u20133","key":"10.1016\/j.apnu.2021.03.006_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2005.10.004","article-title":"Escalated aggressive behavior: Dopamine, serotonin and GABA","volume":"526","author":"de Almeida","year":"2005","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"10.1016\/j.apnu.2021.03.006_bb0055","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4088\/JCP.v63n0807","article-title":"Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: An open-label study","volume":"63","author":"Denys","year":"2002","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.apnu.2021.03.006_bb0060","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1542\/peds.111.3.564","article-title":"Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: The adverse childhood experiences study","volume":"111","author":"Dube","year":"2003","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.apnu.2021.03.006_bb0065","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington\u2019s disease before diagnosis: The predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.apnu.2021.03.006_bb0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/jnp.2010.22.2.196","article-title":"\u201cfrontal\u201d behaviors before the diagnosis of Huntington\u2019s disease and their relationship to markers of disease progression: Evidence of early lack of awareness","volume":"22","author":"Duff","year":"2010","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"2","key":"10.1016\/j.apnu.2021.03.006_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1176\/appi.ajp.2015.14121551","article-title":"Longitudinal psychiatric symptoms in prodromal Huntington\u2019s disease: A decade of data","volume":"173","author":"Epping","year":"2016","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.apnu.2021.03.006_bb0080","first-page":"1","article-title":"State-of-the-art pharmacological approaches to reduce chorea in Huntington\u2019s disease","author":"Gibson","year":"2021","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.apnu.2021.03.006_bb0085","article-title":"Perceived effects of neuropsychiatric symptoms on functional status in early-stage Huntington disease","author":"Gibson","year":"2021","journal-title":"Western Journal of Nursing Research"},{"key":"10.1016\/j.apnu.2021.03.006_bb0090","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"Journal of Biomedical Informatics"},{"issue":"2","key":"10.1016\/j.apnu.2021.03.006_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"Journal of Biomedical Informatics"},{"issue":"4","key":"10.1016\/j.apnu.2021.03.006_bb0100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/mds.22412","article-title":"Health-related quality of life in Huntington\u2019s disease: Which factors matter most?","volume":"24","author":"Ho","year":"2009","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/j.apnu.2021.03.006_bb0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/msj.20041","article-title":"Anxiety disorders: A comprehensive review of pharmacotherapies","volume":"75","author":"Hoffman","year":"2008","journal-title":"Mount Sinai Journal of Medicine"},{"key":"10.1016\/j.apnu.2021.03.006_bb0110","unstructured":"Huntington's Disease Society of America. (2020). What is Huntington's Disease? Retrieved from http:\/\/hdsa.org\/what-is-hd\/."},{"issue":"9","key":"10.1016\/j.apnu.2021.03.006_bb0115","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/jnnp.2006.103309","article-title":"Psychiatric disorders in preclinical Huntington\u2019s disease","volume":"78","author":"Julien","year":"2007","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.apnu.2021.03.006_bb0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jad.2019.03.043","article-title":"Suicidal ideation and behavior in Huntington\u2019s disease: Systematic review and recommendations","volume":"250","author":"Kachian","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.apnu.2021.03.006_bb0125","first-page":"4","article-title":"Huntington disease nursing education, as an evidence-based intervention for reducing the impact of the \u201cCuckoo in the nest\u201d phenomenon in NSW aged care facilities","volume":"17","author":"Lownie","year":"2005","journal-title":"Australasian Journal of Neuroscience"},{"issue":"5","key":"10.1016\/j.apnu.2021.03.006_bb0130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/01612840.2016.1157228","article-title":"Effective strategies for nurses empowering clients with schizophrenia: Medication use as a tool in recovery","volume":"37","author":"Mahone","year":"2016","journal-title":"Issues in Mental Health Nursing"},{"key":"10.1016\/j.apnu.2021.03.006_bb0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5334\/tohm.231","article-title":"The many facets of unawareness in Huntington disease","volume":"4","author":"McCusker","year":"2014","journal-title":"Tremor and Other Hyperkinetic Movements"},{"issue":"1","key":"10.1016\/j.apnu.2021.03.006_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2003.09.010","article-title":"What\u2019s atypical about atypical antipsychotic drugs?","volume":"4","author":"Meltzer","year":"2004","journal-title":"Current Opinion in Pharmacology"},{"issue":"8","key":"10.1016\/j.apnu.2021.03.006_bb0145","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4088\/JCP.15m10511","article-title":"Effectiveness of supplementary cognitive-behavioral therapy for pharmacotherapy-resistant depression: A randomized controlled trial","volume":"78","author":"Nakagawa","year":"2017","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.apnu.2021.03.006_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brainresbull.2006.10.027","article-title":"Comprehensive care in Huntington\u2019s disease: A physician\u2019s perspective","volume":"72","author":"Nance","year":"2007","journal-title":"Brain Research Bulletin"},{"issue":"4","key":"10.1016\/j.apnu.2021.03.006_bb0155","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1176\/appi.ajp.162.4.725","article-title":"Critical periods of suicide risk in Huntington\u2019s disease","volume":"162","author":"Paulsen","year":"2005","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.apnu.2021.03.006_bb0160","series-title":"Columbia-suicide severity rating scale (C-SSRS)","author":"Posner","year":"2008"},{"issue":"2","key":"10.1016\/j.apnu.2021.03.006_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JHD-130051","article-title":"Quality of life in Huntington\u2019s disease: A comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners","volume":"2","author":"Read","year":"2013","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"3","key":"10.1016\/j.apnu.2021.03.006_bb0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1034\/j.1600-0404.2000.102003150.x","article-title":"High suicidal ideation in persons testing for Huntington\u2019s disease","volume":"102","author":"Robins Wahlin","year":"2000","journal-title":"Acta Neurologica Scandinavica"},{"issue":"11","key":"10.1016\/j.apnu.2021.03.006_bb0175","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.37.11.1736","article-title":"Perseveration in behavioral neurology","volume":"37","author":"Sandson","year":"1987","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.apnu.2021.03.006_bb0180","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1212\/WNL.0000000000003661","article-title":"Substance abuse may hasten motor onset of Huntington disease: Evaluating the enroll-HD database","volume":"88","author":"Schultz","year":"2017","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.apnu.2021.03.006_bb0185","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.apnu.2021.03.006_bb0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0277-9536(03)00155-2","article-title":"Predictive genetic test decisions for Huntington\u2019s disease: Context, appraisal and new moral imperatives","volume":"58","author":"Taylor","year":"2004","journal-title":"Social Science & Medicine"},{"issue":"1","key":"10.1016\/j.apnu.2021.03.006_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease","volume":"24","author":"Thompson","year":"2012","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"6","key":"10.1016\/j.apnu.2021.03.006_bb0200","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/jgc4.1245","article-title":"Psychological reactions to predictive genetic testing for Huntington\u2019s disease: A qualitative study","volume":"29","author":"Tiller\u00e5s","year":"2020","journal-title":"Journal of Genetic Counseling"},{"issue":"5","key":"10.1016\/j.apnu.2021.03.006_bb0205","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.psy.48.5.400","article-title":"The impact of Huntington's disease on family life","volume":"48","author":"Vamos","year":"2007","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.apnu.2021.03.006_bb0210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.psychres.2011.05.006","article-title":"Suicidal ideation in Huntington disease: The role of comorbidity","volume":"188","author":"Wetzel","year":"2011","journal-title":"Psychiatry Research"},{"issue":"10","key":"10.1016\/j.apnu.2021.03.006_bb0215","first-page":"3498","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.apnu.2021.03.006_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.12968\/bjnn.2016.12.4.185","article-title":"Knowledge in practice: The specialist nurse role in Huntington\u2019s disease","volume":"12","author":"Wilson","year":"2016","journal-title":"British Journal of Neuroscience Nursing"}],"container-title":["Archives of Psychiatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941721000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941721000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:29:35Z","timestamp":1760124575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883941721000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0883941721000492"],"URL":"https:\/\/doi.org\/10.1016\/j.apnu.2021.03.006","relation":{},"ISSN":["0883-9417"],"issn-type":[{"value":"0883-9417","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing","name":"articletitle","label":"Article Title"},{"value":"Archives of Psychiatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apnu.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}